Our Focus
Progenra’s mission is to leverage its expertise in the ubiquitin proteasome system, Molecular Glues and, PROTAC drugs to discover and develop novel, first in class medicines to fill unmet needs in a spectrum of therapeutic areas.
News
Blog
The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson’s Disease
The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson’s Disease Progenra Inc, February 2023 Parkinson’s disease (PD) is the most common neurodegenerative movement disorder. There are no available therapeutics that slow or halt the progressive loss of...
Leadership in Ubiquitin Drug Discovery
UbiPro Platform
PROTAC Platform
Therapeutic Areas